3'-Azido-3'-deoxythymidine β-D-glucuronide (sodium salt) Size:Contact [email protected] for quotation ) increases the latency to

) increases the latency to clonic and generalized seizures

(source: Mol Cancer Ther

Formula: C34H47NO10

CC[C@H](C)[C@H](NC(=O)[C@H](CC1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1C=CC=CC=1)C(O)=O

MDA19 behaved as an agonist at the rat CB1 receptor and exhibited no functional activity at the rat CB(2) receptor

3'-Azido-3'-deoxythymidine β-D-glucuronide (sodium salt) Size:Contact [email protected] for quotation ) increases the latency to3' Azido 3' deoxythymidine D glucuronide is the metabolite of zidovudine, a nucleoside reverse transcriptase inhibitor. Zidovudine, an antiretroviral medication used to prevent and treat HIV, is recommended for use with other antiretroviral and may be also used to prevent mother to child spread during birth or after a needlestick injury or other potential exposure. In vitro: 3' Azido 3' deoxythymidine D glucuronide is a metabolite of zidovudine,